Skip to main
DCGO

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

DocGo is positioned well in the growing market of last-mile mobile health services and integrated medical mobility solutions. Its proprietary logistics platform and lower-cost staffing model give it a competitive advantage in accessing this market opportunity. Despite a dip in revenue and adj-EBITDA expected in 2026 as a result of transitioning years, the company is expected to experience mid-teens-plus secular growth after 2026. Furthermore, recent developments such as expanded partnerships and increased patient volumes demonstrate the potential for future growth and differentiation in the industry.

Bears say

DocGo is heavily reliant on its Mobile Health Services segment, which faces challenges in scaling its revenue and right-sizing its costs. While the company's acquisition of SteadyMD and expansion into the value-based care market show potential, there is concern about the slow growth of its core business. The uncertainty surrounding the dissipation of COVID-related revenue and the company's ability to meet its forecasts also adds to the negative outlook. Overall, there is a need for DocGo to prove its ability to sustain and grow its business to justify its current valuation.

DocGo (DCGO) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Buy based on their latest research and market trends.

According to 4 analysts, DocGo (DCGO) has a Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.